{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:06:14Z","timestamp":1791223574807,"version":"4.1.0"},"reference-count":61,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2013,7,27]],"date-time":"2013-07-27T00:00:00Z","timestamp":1374883200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CNS Neurosci Ther"],"published-print":{"date-parts":[[2013,11]]},"abstract":"<jats:title>Summary<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The close relationship between epileptic seizure and Alzheimer's disease (<jats:styled-content style=\"fixed-case\">AD<\/jats:styled-content>) has been demonstrated in the past decade. Valproic acid, a traditional first\u2010line antiepileptic drug, exerted protective effects in transgenic models of <jats:styled-content style=\"fixed-case\">AD<\/jats:styled-content>. It remains uncertain whether new antiepileptic drugs could reverse neuropathology and behavioral deficits in <jats:styled-content style=\"fixed-case\">AD<\/jats:styled-content> transgenic mice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aims<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">APP<\/jats:styled-content>swe\/<jats:styled-content style=\"fixed-case\">PS<\/jats:styled-content>1dE9 transgenic mice were used in this study, which over express the Swedish mutation of amyloid precursor protein together with presenilin 1 deleted in exon 9. 7\u2010month\u2010old <jats:styled-content style=\"fixed-case\">APP<\/jats:styled-content>swe\/<jats:styled-content style=\"fixed-case\">PS<\/jats:styled-content>1dE9 transgenic mice were treated daily with 20\u00a0mg\/kg topiramate (<jats:styled-content style=\"fixed-case\">TPM<\/jats:styled-content>) and 50\u00a0mg\/kg levetiracetam (<jats:styled-content style=\"fixed-case\">LEV<\/jats:styled-content>) for 30\u00a0days by intraperitoneal injection to explore the effects of <jats:styled-content style=\"fixed-case\">TPM<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">LEV<\/jats:styled-content> on the neuropathology and behavioral deficits.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The results indicated that <jats:styled-content style=\"fixed-case\">TPM<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">LEV<\/jats:styled-content> alleviated behavioral deficits and reduced amyloid plaques in <jats:styled-content style=\"fixed-case\">APP<\/jats:styled-content>swe\/<jats:styled-content style=\"fixed-case\">PS<\/jats:styled-content>1dE9 transgenic mice. <jats:styled-content style=\"fixed-case\">TPM<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">LEV<\/jats:styled-content> increased A\u03b2 clearance and up\u2010regulated A\u03b2 transport and autophagic degradation. <jats:styled-content style=\"fixed-case\">TPM<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">LEV<\/jats:styled-content> inhibited A\u03b2 generation and suppressed \u03b3\u2010secretase activity. <jats:styled-content style=\"fixed-case\">TPM<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">LEV<\/jats:styled-content> inhibited <jats:styled-content style=\"fixed-case\">GSK<\/jats:styled-content>\u20103\u03b2 activation and increased the activation of <jats:styled-content style=\"fixed-case\">AMPK<\/jats:styled-content>\/Akt activation. Further, <jats:styled-content style=\"fixed-case\">TPM<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">LEV<\/jats:styled-content> inhibited histone deacetylase activity <jats:italic>in vivo<\/jats:italic>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Therefore, <jats:styled-content style=\"fixed-case\">TPM<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">LEV<\/jats:styled-content> might have the potential to treat <jats:styled-content style=\"fixed-case\">AD<\/jats:styled-content> effectively in patient care.<\/jats:p><\/jats:sec>","DOI":"10.1111\/cns.12144","type":"journal-article","created":{"date-parts":[[2013,7,27]],"date-time":"2013-07-27T03:44:34Z","timestamp":1374896674000},"page":"871-881","source":"Crossref","is-referenced-by-count":117,"title":["Antiepileptics Topiramate and Levetiracetam Alleviate Behavioral Deficits and Reduce Neuropathology in <scp>APP<\/scp>swe\/<scp>PS<\/scp>1dE9 Transgenic Mice"],"prefix":"10.1111","volume":"19","author":[{"given":"Jian\u2010Quan","family":"Shi","sequence":"first","affiliation":[{"name":"Department of Neurology Nanjing First Hospital Nanjing Medical University Nanjing Jiangsu Province China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bian\u2010Rong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology Jiangsu Geriatric Hospital Nanjing Jiangsu Province China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You\u2010Yong","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Neurology Nanjing First Hospital Nanjing Medical University Nanjing Jiangsu Province China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Neurology Affiliated Nanjing Brain Hospital Nanjing Medical University Nanjing Jiangsu Province China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Neurology Affiliated Nanjing Brain Hospital Nanjing Medical University Nanjing Jiangsu Province China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu\u2010Li","family":"Zhao","sequence":"additional","affiliation":[{"name":"Central Laboratory Nanjing First Hospital Nanjing Medical University Nanjing Jiangsu Province China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Neurology Nanjing First Hospital Nanjing Medical University Nanjing Jiangsu Province China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong\u2010Guang","family":"Xie","sequence":"additional","affiliation":[{"name":"Central Laboratory Nanjing First Hospital Nanjing Medical University Nanjing Jiangsu Province China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying\u2010Dong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology Nanjing First Hospital Nanjing Medical University Nanjing Jiangsu Province China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,7,27]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.18.2335"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2006.09.016"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-neuro-061010-113613"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006247"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1566067"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2011.07458.x"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.36.9.1226"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.46.3.727"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2006.00554.x"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2009.15"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2007.07.025"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.5215-08.2009"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2009.09.002"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/nn.2801"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2012.03.023"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20081588"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2011.03.006"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0013-9580.2004.00104.x"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0013-9580.2004.13504.x"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.braindev.2010.06.008"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2012.05.021"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddh019"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/517160"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2010.10.053"},{"key":"e_1_2_7_26_1","unstructured":"RasbandWS.ImageJ v1. Bethesda Maryland: U. S. National Institutes of Health 1997\u20132011.http:\/\/rsb.info.nih.gov\/ij\/."},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.21-02-00372.2001"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1186088"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature10849"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2012.05.042"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2012.06.012"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2012.01.001"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2012.07.013"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.356584"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2011.10.031"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2011.01.003"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2009.09.003"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318230a16c"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2011.72"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70153-9"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000128029.50221.fa"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2011.03.069"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033519"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1053\/seiz.2000.0511"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2006.00454.x"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2011.05.017"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12017-012-8173-2"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/cdf636"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2010.07.081"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.060061"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2012-111649"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.10-167361"},{"key":"e_1_2_7_53_1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000276710","article-title":"Autophagy dysfunction in Alzheimer's disease","volume":"7","author":"Li L","year":"2010","journal-title":"Neurodegener Dis"},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2011.01.021"},{"key":"e_1_2_7_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2012.07.003"},{"key":"e_1_2_7_56_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1197623"},{"key":"e_1_2_7_57_1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3233\/JAD-2010-100021","article-title":"Impairments in brain\u2010to\u2010blood transport of amyloid\u2010\u03b2 and reabsorption of cerebrospinal fluid in an animal model of Alzheimer's disease are reversed by antisense directed against amyloid\u2010\u03b2 protein precursor","volume":"23","author":"Banks WA","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"e_1_2_7_58_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000143452.85382.d1"},{"key":"e_1_2_7_59_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1121081109"},{"key":"e_1_2_7_60_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318206ca02"},{"key":"e_1_2_7_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2009.10.001"},{"key":"e_1_2_7_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2006.10.001"}],"container-title":["CNS Neuroscience &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcns.12144","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cns.12144","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T03:37:41Z","timestamp":1696217861000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cns.12144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,27]]},"references-count":61,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["10.1111\/cns.12144"],"URL":"https:\/\/doi.org\/10.1111\/cns.12144","archive":["Portico"],"relation":{},"ISSN":["1755-5930","1755-5949"],"issn-type":[{"value":"1755-5930","type":"print"},{"value":"1755-5949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,27]]}}}